These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36173618)

  • 1. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
    Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Sinusitis and Risk of Head and Neck Cancer in the US Elderly Population.
    Beachler DC; Engels EA
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):25-31. PubMed ID: 27606895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
    Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
    J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
    Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
    Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.
    Tsai CJ; McBride SM; Riaz N; Kang JJ; Spielsinger DJ; Waldenberg T; Gelblum D; Yu Y; Chen LC; Zakeri K; Wong RJ; Dunn L; Pfister DG; Sherman EJ; Lee NY
    JAMA Oncol; 2022 Mar; 8(3):364-372. PubMed ID: 35050342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
    Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
    JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
    Fullerton ZH; Butler SS; Mahal BA; Muralidhar V; Schoenfeld JD; Tishler RB; Margalit DN
    Cancer; 2020 Apr; 126(7):1424-1433. PubMed ID: 31930488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
    Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.
    Riaz N; Sherman E; Koutcher L; Shapiro L; Katabi N; Zhang Z; Shi W; Fury M; Wong R; Wolden S; Rao S; Lee N
    Am J Clin Oncol; 2016 Feb; 39(1):27-31. PubMed ID: 24401670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
    Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
    Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Huang SH; Jacinto JCK; O'Sullivan B; Su J; Kim J; Ringash J; Spreafico A; Yu E; Perez-Ordonez B; Weinreb I; Cho J; Hope AJ; Bratman SV; Giuliani ME; Hosni A; Hahn E; Goldstein DP; Tong L; Eng L; Xu W; Waldron JN
    Cancer; 2022 Aug; 128(15):2908-2921. PubMed ID: 35588085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
    Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The "ALARM" study.
    Agelaki S; Boukovinas I; Athanasiadis I; Trimis G; Dimitriadis I; Poughias L; Morais E; Sabale U; Bencina G; Athanasopoulos C
    Cancer Med; 2024 Feb; 13(3):e6916. PubMed ID: 38247106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
    Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
    Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.